Press Releases

Page Category: 

Revenues Hit $75.7 Million in the Quarter, Up 10%

Year-to-Date Revenues Reach $219.5 Million, Up 18%

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 25, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2011.

REVENUE

Revenues for the third quarter of 2011 were $75.7 million, rising 10% in comparison to $68.5 million in the third quarter of 2010.

Revenues for the nine months of 2011 were $219.5 million, compared to $186.1 million in 2010, an increase of 18%.

Overall order booking rates increased 16% in the quarter.

Foreign exchange contributed to a 2.1% favorable impact on third quarter results and a 2.8% favorable impact on the first nine months of 2011.

EBITDAS, EBITDA and OPERATING INCOME (EBIT)

Third Quarter:

For the quarter, EBITDAS includes non-recurring severance charges of $1.3 million from SG&A cost restructuring. Operating expense run rate savings are projected at $6.0 million for 2012, positioning the company for improved operating margins while launching new products and driving marketing initiatives in 2012.

Sponsored by Mt. Sinai Hospital, The Louis J. Acompora Memorial Foundation, and The Dominic A. Murray 21 Memorial Foundation Free Screening October 22nd at Northport High School, Northport, New York

BOTHELL, WA - October 20, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside ultrasound for point-of-care medicine, proudly supports a community heart health screening to raise awareness and prevent sudden cardiac arrest in young adults.

Sponsored by the Louis J. Acompora Memorial Foundation , the Dominic A. Murray 21 Memorial Foundation and The Mount Sinai Hospital , the company will be providing physicians with its flagship M-Turbo ultrasound systems to perform a non-invasive cardiac ultrasound examination for the accurate evaluation of heart functionality, valve complications, and blood flow. Students between the ages of 14-24 are eligible for a free heart screening. The event will take place on October 22nd at the Northport High School in New York.

A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs

Non-invasive System to Assist in Fluid Management

Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242

BOTHELL, WA - October 13, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient's hemodynamic profile in the hospital. Pioneered by NASA in the 1960's, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.

BOTHELL, WA—October 6, 2011—Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that it will report the company's third quarter financial results on Tuesday, October 25, 2011 at the close of market and will host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via Sonosite's website at http://www.sonosite.com/about/investors .

A replay of the audio webcast will be available beginning October 25th at 4:30 pm PT and will be available until November 8th at 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7745091 is required to access the replay. The call will also be archived on Sonosite's website.

About Sonosite

Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - August 11, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Mehran Mehrtash as Vice President and General Manager of Asia Pacific and the Middle East. Mr. Mehrtash's appointment will aid in the further development of the Asia Pacific region and the company's plans to expand its footprint in China and South Korea; two emerging markets with high growth potential.

"I am excited to welcome Mehran to the Sonosite team, said Mr. Kevin M. Goodwin, Sonosite's President and CEO. "He has a successful track record in the Asia Pacific region and his addition is imperative as we sharpen our focus on expanding in China and South Korea. With an existing appetite for new and innovative technology in these markets, I am confident that Mehran's leadership will enable the company to hit our growth targets."

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA – July 25, 2011 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the second quarter ended June 30, 2011.

REVENUE Revenue for the second quarter of 2011 was $72.7 million, an increase of 18% compared to $61.5 million in the second quarter of 2010.

Revenue for the first half of 2011 was $143.8 million compared to $117.5 million in 2010, an increase of 22%.

Revenue from VisualSonics (VSI), Inc. was $8.3 million for the quarter, up 7%. Revenues were $16.5 million for the first half of 2011, up 5%.

Foreign exchange contributed to a 4% favorable impact on second quarter results and a 3% favorable impact on the first half of 2011.

Revenues were also negatively impacted in the second quarter by a series of delayed orders between $4.0-$5.0 million.

SECOND QUARTER, FIRST HALF, AND MARKETING MILESTONES

Increased Use of Bedside Ultrasound Drives Remarkable Patient Outcomes: Zero Incidents of a Common Complication - Iatrogenic Pneumothorax (Collapsed Lung) - for Up to 36 Months

BOTHELL, WA - July 21, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside ultrasound for point-of-care medicine, congratulates Memorial Hermann Healthcare System (Memorial Hermann), one of the Nation's largest non-profit healthcare systems, for its excellence in delivering the highest level of patient safety by achieving "inspiring" safety results previously never thought possible. Four years ago, Memorial Hermann instituted a network-wide patient safety initiative as a part of its "journey to providing high reliability healthcare" and to meet national patient safety goals. To reward safety success stories, the healthcare system created a "Certified Zero High Reliability Award" acknowledging facilities that achieved a zero complication rate for a full-year or more for certain events and procedures. By introducing...

Chief Operating Officer, Jack Sparacio

Global Chief Marketing Officer, Matthew Damron

Largest Study Documents the Benefits of "Ultrasound Guided" Procedures: Paracentesis & Thoracentesis

Results Show Substantial Improvements in Complications and Large Potential Impact on Cost of Care for Hospitals:

Fewer patients with collapsed lungs, bleeding complications, and decreased length of stay in hospital

BOTHELL, WA - May 26, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for point-of-care medicine, today announced that Diku Mandavia, MD, Sonosite's Chief Medical Officer, will present two new research studies that define the economic value of point-of-care visualization in reducing medical errors, complications and costs in patients who underwent a paracentesis or thoracentesis, two commonly performed needle-based procedures in the hospital. This is the first and largest study to compare the economic and safety benefits of patients who received a thoracentesis or paracentesis with and without ultrasound guidance. This robust study was completed by the United BioSource Corporation...

27% REVENUE GROWTH TO $71.1 Million 51% EBIT GROWTH TO $4.0 Million 52% EBITDA GROWTH TO $6.6 Million 62% EBITDAS GROWTH TO $8.7 Million

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - April 25, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the first quarter ended March 31, 2011.

REVENUE Revenue for the first quarter of 2011 was $71.1 million, an increase of 27% compared to $56.0 million in the first quarter of 2010. Revenue from VisualSonics, Inc., acquired in June 2010, was $8.2 million for the quarter.

Foreign currency rates had a 2% favorable impact on first quarter revenue results.

FIRST QUARTER HIGHLIGHTS

The US Sector delivered another quarter of double-digit revenue growth, up $4.5 million or 21%; Strong performance by the US Enterprise channel, which grew 71% compared to the prior year; VisualSonics successfully launched the Vevo® LAZR Photoacoustics Imaging system at the American Association of Cancer Research, receiving positive feedback and interest among scientific researchers.

EBITDAS, EBITDA and Operating Income (EBIT) First Quarter Results First quarter EBITDAS was $8.7 million or 12% of revenue, an increase of 62% over the prior year.